Cutaneous leukocytoclastic vasculitis due to erlotinib: just an adverse event or also a putative marker of drug efficacy?

Author: Brandi Giovanni   Venturi Michela   Dika Emi   Maibach Howard   Patrizi Annalisa   Biasco Guido  

Publisher: Informa Healthcare

ISSN: 1556-9527

Source: Cutaneous and Ocular Toxicology (formerly Journal of Toxicology - Cutaneous and, Vol.32, Iss.4, 2013-12, pp. : 336-338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content